| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/11/1992 | EP0473721A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
| 03/11/1992 | EP0473716A1 Dominant negative members of the steroid/thyroid superfamily of receptors |
| 03/11/1992 | EP0473693A1 Target-dependent synthesis of a replicatable rna. |
| 03/11/1992 | EP0473576A1 SHORT THERAPEUTIC dsRNA OF DEFINED STRUCTURE |
| 03/11/1992 | EP0435877A4 Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response |
| 03/11/1992 | EP0431042A4 A method of preparing an active human neutrophil chemotactic factor polypeptide |
| 03/11/1992 | EP0205506B1 A method of transforming fungi with a vector |
| 03/11/1992 | EP0200757B1 Promotion of wound healing with human epidermal growth factor prepared from recombinant dna |
| 03/10/1992 | US5095096 Fused protein comprising lymphotoxin |
| 03/10/1992 | US5094953 Human tissue plasminogen activator variants |
| 03/10/1992 | US5094951 Genetic engineering |
| 03/10/1992 | US5094945 Inhibition resistant 5-enolpyruvyl-3-phosphoshikimate synthase, production and use |
| 03/10/1992 | US5094941 Monoclonal antibodies to PDGF |
| 03/10/1992 | CA1297051C Expression of the cloned lysostaphin gene |
| 03/10/1992 | CA1297050C Expression systems for over production of desired proteins |
| 03/10/1992 | CA1297049C Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein |
| 03/09/1992 | CA2050876A1 Recombinant expression vectors capable of expressing immunogenic malarial antigens on the surface of salmonella vaccine strains |
| 03/08/1992 | CA2050850A1 Recombinant herpes viruses, a vaccine based on these recombinants, their preparation process, genes, vectors and plasmids used in this process |
| 03/08/1992 | CA2050743A1 Expression of genes encoding plant pathogenesis related proteins in plant associated bacteria |
| 03/06/1992 | WO1992004441A1 Production of human lysozyme in methylotrophic yeast cells and efficient secretion therefrom |
| 03/06/1992 | CA2089752A1 Production of human lysozyme in methylotrophic yeast cells and efficient secretion therefrom |
| 03/05/1992 | WO1992004463A1 Cd58-specific monoclonal antibodies and their use |
| 03/05/1992 | WO1992003733A1 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus |
| 03/05/1992 | WO1992003570A1 Monoclonal antibodies capable of binding to human and rat insulin |
| 03/05/1992 | WO1992003569A1 Protein polyligands joined to a stable protein core |
| 03/05/1992 | WO1992003568A1 Sugar modified oligonucleotides that detect and modulate gene expression |
| 03/05/1992 | WO1992003566A1 Therapeutic ribozyme compositions |
| 03/05/1992 | WO1992003562A1 Dna, dna constructs, cells and plants derived therefrom |
| 03/05/1992 | WO1992003560A1 A method for rapid selection of efficient secretion vectors |
| 03/05/1992 | WO1992003557A1 RECOMBINANT DNA PRODUCTION OF β-1,3-GLUCANASE |
| 03/05/1992 | WO1992003556A1 PURIFIED THERMOSTABLE NUCLEIC ACID POLYMERASE ENZYME FROM $i(TERMOTOGA MARITIMA) |
| 03/05/1992 | WO1992003554A1 Infectious laryngotracheitis virus vaccine |
| 03/05/1992 | WO1992003553A1 Footrot vaccine |
| 03/05/1992 | WO1992003552A1 P. falciparum-infected red corpuscles and immunogenic compositions containing same |
| 03/05/1992 | WO1992003550A1 Ryegrass pollen allergen |
| 03/05/1992 | WO1992003549A1 Specific dna sequences of a nematode which can be used for the diagnosis of infection with the nematode |
| 03/05/1992 | WO1992003548A1 Human zona pellucida protein zp3 |
| 03/05/1992 | WO1992003547A1 MAREK'S DISEASE HERPESVIRUS DNA SEGMENT ENCODING GLYCOPROTEINS, gD, gI AND gE |
| 03/05/1992 | WO1992003546A1 Enhancement of production of native products in corynebacterium by expression of cloned bacterial hemoglobin |
| 03/05/1992 | WO1992003545A1 Flavivirus recombinant poxvirus vaccine |
| 03/05/1992 | WO1992003540A1 Enzymes with xylanolytic activity |
| 03/05/1992 | WO1992003539A1 Virus resistance in plants |
| 03/05/1992 | WO1992003537A1 Self-assembling replication defective hybrid virus particles |
| 03/05/1992 | WO1992003535A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same |
| 03/05/1992 | WO1992003477A1 Biologically active compound, a process for the preparation thereof and use of the same |
| 03/05/1992 | WO1992003467A1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 03/05/1992 | WO1992003457A1 Entamoeba histolytica immunodominant surface antigens |
| 03/05/1992 | WO1992003456A1 Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 03/05/1992 | WO1992003139A1 Oligonucleotide modulation of cell adhesion |
| 03/05/1992 | WO1992003041A1 Method for producing transformed chrysanthemum plants |
| 03/05/1992 | WO1992001794A3 Ancrod-like proteins, their preparation and their use |
| 03/05/1992 | WO1991015516A3 Hepatitis c virus epitopes |
| 03/05/1992 | DE4027154A1 Mutation der hrv2 2a Mutation of HRV2 2a |
| 03/05/1992 | CA2090337A1 Enzymes with xylanolytic activity |
| 03/05/1992 | CA2090105A1 Protein polyligands joined to a stable protein core |
| 03/05/1992 | CA2089497A1 Self-assembling replication defective hybrid virus particles |
| 03/05/1992 | CA2087977A1 Plant fatty acid synthases |
| 03/05/1992 | CA2081770A1 A cd58-specific monoclonal antibody and the use thereof |
| 03/05/1992 | CA2069962A1 Recombinant dna production of beta-1, 3-glucanase |
| 03/05/1992 | CA2066160A1 Marek's disease herpesvirus dna segment encoding glycoproteins, gd, gi and ge |
| 03/04/1992 | EP0473253A1 Mammalian centromere containing human DNA sequences associated with a dominant marker |
| 03/04/1992 | EP0473210A2 Recombinant Marek's disease virus |
| 03/04/1992 | EP0473155A2 Controlled initial target-dependent production of templates for ligase chain reaction |
| 03/04/1992 | EP0473128A2 Monoclonal antibody specifically reactive with human perforin |
| 03/04/1992 | EP0473111A2 Recombinant mite allergen |
| 03/04/1992 | EP0473080A2 Chondromodulin-I protein |
| 03/04/1992 | EP0472987A1 Antimicrobial peptides active against plant pathogens, their use and screening methods pertaining thereto |
| 03/04/1992 | EP0472869A2 Plasmids of corynebacterium glutamicum and derived plasmid vectors |
| 03/04/1992 | EP0472722A1 Plant desaturases - compositions and uses |
| 03/04/1992 | EP0472712A1 Novel sequences preferentially expressed in early seed development and methods related thereto |
| 03/04/1992 | EP0472662A1 Antifreeze polypeptides |
| 03/04/1992 | EP0472659A1 T-lymphotropic retrovirus monoclonal antibodies |
| 03/04/1992 | EP0472658A1 Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification |
| 03/04/1992 | EP0472638A1 Method for isolating receptors having a preselected specificity |
| 03/04/1992 | EP0472599A1 Methods and systems for determining the presence of a pneumocystis carinii antigen in blood |
| 03/04/1992 | EP0472579A1 Ribosomal frameshift signals and uses |
| 03/04/1992 | EP0472573A1 Herbicide resistant maize. |
| 03/04/1992 | EP0328542B1 Antiparathyroid antibody preparation |
| 03/03/1992 | US5093261 Monoclonal antibodies |
| 03/03/1992 | US5093260 Process for creating, in particular in the earth gravitational field conditions of microgravity for cell culture |
| 03/03/1992 | US5093258 For expressing immunogenic proteins, poultry vaccines |
| 03/03/1992 | US5093257 Hybrid prokaryotic polypeptides produced by in vivo homologous recombination |
| 03/03/1992 | US5093252 Transcription terminator and related recombinant DNA vectors and transformants |
| 03/03/1992 | US5093251 Cassette method of gene synthesis |
| 03/03/1992 | US5093246 Rna ribozyme polymerases, dephosphorylases, restriction endoribo-nucleases and methods |
| 03/03/1992 | US5093245 Labeling by simultaneous ligation and restriction |
| 03/03/1992 | US5093242 Methods of generating desired amino-terminal residues in proteins |
| 03/03/1992 | US5093241 C-terminal cat fusion protein and process of preparation by recombinant dna |
| 03/03/1992 | CA1296664C Oligonucleoside alkyl or arylphosphonate derivatives capable of crosslinking with or cleaving nucleic acids |
| 03/03/1992 | CA1296663C Arabinonucleic acid probes for dna/rna assays |
| 03/03/1992 | CA1296662C Hybridoma cell lines and their monoclonal antibodies to human pluripotent granulocyte colony stimulating factor |
| 03/03/1992 | CA1296661C Monoclonal antibodies specific for synthetic glycosphingolipids |
| 03/03/1992 | CA1296660C Monoclonal antibody against a ras oncogene p21 related dodecapeptide |
| 03/03/1992 | CA1296604C Method for releasing rna and dna from cells |
| 03/01/1992 | WO1992005760A1 Method and compositions for diagnosing and treating chronic fatigue immunodysfunction syndrome |
| 03/01/1992 | WO1992004455A1 Multidomain hematopoiesis stimulators |
| 03/01/1992 | WO1992004034A1 Method for treating endotoxin shock using anti-adhesion antibodies |
| 03/01/1992 | WO1992003555A1 Mutation of hrv2 2a |
| 03/01/1992 | WO1992003471A1 New insulin-like growth factor binding protein igfbp-5 |
| 03/01/1992 | WO1992003470A1 Genetic material encoding igfbp-5 |